Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Marketing Practices Under Investigation By California, Alaska

This article was originally published in The Pink Sheet Daily

Executive Summary

Separate inquiries into Seroquel launched in September; promotional activities also being scrutinized by U.S. Attorney in Los Angeles.

You may also be interested in...



Lilly, AstraZeneca, Cephalon Marketing Practices Under Review By House Committee

Rep. Waxman is requesting information into the marketing of Zyprexa, Seroquel, Actiq and Fentora.

Lilly, AstraZeneca, Cephalon Marketing Practices Under Review By House Committee

Rep. Waxman is requesting information into the marketing of Zyprexa, Seroquel, Actiq and Fentora.

Antipsychotic Marketing Investigation Broadens

Pfizer and Lilly join AstraZenenca under California attorney general’s microscope for marketing practices related to antipsychotics.

Related Content

Topics

UsernamePublicRestriction

Register

RS150923

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel